Startup profile · funding coverage
Alchemy Health funding, valuation and investors
End-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics.
Keep track of Alchemy Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$31M · 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$31M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed
Investors in latest funding
Other: Andreessen Horowitz
Overview
Alchemy Health builds end-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics — helping safety-net providers dispense medications and improve adherence.
Why Alchemy Health is interesting
Founders from Truepill and global HIV access work — targets safety-net clinics where pharmacy friction drives adherence gaps.
Product & use cases
Alchemy Health builds end-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics — helping safety-net providers dispense medications and improve adherence.
- Healthcare provider and health-system operations
Key facts
- Seed (2024): $31M led by a16z Bio + Health with AlleyCorp, Twine Ventures, Springbank (company press)
- Magic Johnson and Sandberg Bernthal also participated (press)
Funding history (newest first)
Seed
2024 $31MSource: Seed (2024): $31M led by a16z Bio + Health with AlleyCorp, Twine Ventures, Springbank (company press)
Investors in our directory
Funds linked from Alchemy Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Founders from Truepill and global HIV access work — targets safety-net clinics where pharmacy friction drives adherence gaps.
Alchemy Health competes in healthtech, biotech-life-sciences. Incumbents have distribution; startup edge depends on product depth and buyer references. See competitors for specific tradeoffs — no invented market share claims.
-
Epic Systems incumbent
Dominant EHR incumbent.
-
Oracle Health incumbent
Enterprise EHR competitor.
-
Veeva incumbent
Life sciences cloud incumbent.
-
Dotmatics adjacent
R&D informatics.
Notable stories
- Seed (2024): $31M led by a16z Bio + Health with AlleyCorp, Twine Ventures, Springbank (company press)
- Magic Johnson and Sandberg Bernthal also participated (press)
Industries
Related funding articles
Venture Capital Tracker pieces that cover Alchemy Health's financing or category context.
FAQs about Alchemy Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.